Janssen/MeiraGTx sight loss gene therapy hits targets

20th July 2020 Uncategorised 0

Interim six-month data of RPGR gene therapy shows significant vision improvement in patients with X-linked retinitis pigmentosa

More: Janssen/MeiraGTx sight loss gene therapy hits targets
Source: News